» Articles » PMID: 33751160

Prediction of Tumor Size in Patients with Invasive Ductal Carcinoma Using FT-IR Spectroscopy Combined with Chemometrics: a Preliminary Study

Overview
Specialty Chemistry
Date 2021 Mar 22
PMID 33751160
Authors
Affiliations
Soon will be listed here.
Abstract

Precise detection of tumor size is essential for early diagnosis, treatment, and evaluation of the prognosis of breast cancer. However, there are some errors between the tumor size of breast cancer measured by conventional imaging methods and the pathological tumor size. Invasive ductal carcinoma (IDC) is a common pathological type of breast cancer. In this study, serum Fourier transform infrared spectroscopy (FT-IR) combined with chemometric methods was used to predict the maximum diameter and maximum vertical diameter of tumors in IDC patients. Three models were evaluated based on the pathological tumor size measured after surgery and included grid search support vector machine regression (GS-SVR), back propagation neural network optimized by genetic algorithm (GA-BP-ANN), and back propagation neural network optimized by particle swarm optimization (PSO-BP-ANN). The results show that three models can accurately predict tumor size. The GA-BP-ANN model provided the best fitting quality of the largest tumor diameter with the determination coefficients of 0.984 in test set. And the GS-SVR model provided the best fitting quality of the largest vertical tumor diameter with the determination coefficients of 0.982 in test set. The GS-SVR model had the highest prediction efficiency and the lowest time complexity of the models. The results indicate that serum FT-IR spectroscopy combined with chemometric methods can predict tumor size in IDC patients. In addition, compared with traditional imaging methods, we found that the experimental results of the three models are better than traditional imaging methods in terms of correlation and fitting degree. And the average fitting error of PSO-BP-ANN and GA-BP-ANN models was less than 0.3 mm. The minimally invasive detection method is expected to be developed into a new clinical diagnostic method for tumor size estimation to reduce the diagnostic trauma of patients and provide new diagnostic experience for patients. Graphical Abstract.

References
1.
Haraldsdottir K, Jonsson B, Halldorsdottir A, Tranberg K, Asgeirsson K . Tumor Size of Invasive Breast Cancer on Magnetic Resonance Imaging and Conventional Imaging (Mammogram/Ultrasound): Comparison with Pathological Size and Clinical Implications. Scand J Surg. 2016; 106(1):68-73. DOI: 10.1177/1457496916631855. View

2.
Dummin L, Cox M, Plant L . Prediction of breast tumor size by mammography and sonography--A breast screen experience. Breast. 2006; 16(1):38-46. DOI: 10.1016/j.breast.2006.04.003. View

3.
Gonzalez-Sistal A, Baltasar Sanchez A, Del Rio M, Arias J, Herranz M, Ruibal A . Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program. Anticancer Res. 2014; 34(1):269-73. View

4.
Bunaciu A, Dang Hoang V, Aboul-Enein H . Applications of FT-IR spectrophotometry in cancer diagnostics. Crit Rev Anal Chem. 2015; 45(2):156-65. DOI: 10.1080/10408347.2014.904733. View

5.
Kochan K, Maslak E, Chlopicki S, Baranska M . FT-IR imaging for quantitative determination of liver fat content in non-alcoholic fatty liver. Analyst. 2015; 140(15):4997-5002. DOI: 10.1039/c5an00737b. View